|
|
Article: HEALTH: EUROPEAN LEUKAEMIA RESEARCH UPDATE
- Article from:
- Europe Environment
- Article date:
- February 25, 1997
CopyrightCOPYRIGHT 1997 Europe Information Service. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Summary: "Signigicant and promising" were the words used by the European Commission's Join t Research Centre on February 20 to describe the lastest breakthrough in research and development work on treatment for leukaemia. Scientists at the JRC's Institu te for Transuranium Elements (ITU), in the German city of Karlsruhe, have develop ed a radioisotope, bismuth-213, which has just entered early clinical trials in t he treatment of leukemia at Memorial Sloan-Kettering Cancer Centre in New York Ci ty. In a statement, the Commission said this progress "emphasises the expertise a cquired by the Joint Research Centre of the European Union in the nuclear field a s well as making ...